Dr. Daryl MacCarter graduated
from Medical School
at the University of Minnesota in Minneapolis. He then completed his medicine residency
training at St. Mary’s Hospital in Waterbury, Connecticut and Yale-New Haven
Hospital in New Haven, Connecticut. Dr. MacCarter completed his fellowship training
in rheumatology at the University of Michigan in Ann Harbor. He is board certified in both rheumatology
and internal medicine. He founded the Idaho Arthritis and Osteoporosis
Center in 2000 after relocating from Denver, Colorado
where he practiced rheumatology for twenty years. He also held an academic position at the University
of Colorado Health Sciences Center and VA hospital for five years. Dr. MacCarter was also Chief of Rheumatology
at Presbyterian St. Luke’s Medical Center in Denver
for fifteen years. He currently holds a teaching appointment at the University of Washington as a clinical assistant
professor of medicine.
In addition to his M.D. degree,
Dr. MacCarter also has a Masters Degree in Pharmacology. He was also nominated
and awarded the status of F.A.C.P. (Fellow
American College
of Physicians) in 1985. He is currently
on the Speakers Bureau for Amgen, Lilly Pharmaceuticals, Proctor & Gamble,
Rosch and GlaxoSmithKline. Dr. MacCarter
is also on the advisory board for Abbott Pharmaceuticals and Amgen. He has been a guest lecturer on the subject
of scleroderma at the University of Groningen in the Netherlands
and also on the subject of pseudogout at the University of Heidelberg in Germany.
Dr. MacCarter’s current practice
includes the treatment of all rheumatic diseases including lupus and rheumatoid
arthritis. His special interests include
the diagnosis and treatment of pseudogout and osteoporosis. He also serves as the principal investigator
for numerous clinical trials in rheumatoid arthritis, osteoarthritis and
osteoporosis. Dr. MacCarter enjoys
sailing, biking and hiking with his wife and two sons.